Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..3 of 3 -
per page
Order by
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases.
More
Therapeutic drugs in late stage development (marketed, registered or in clinical trials) are sought to complement our product portfolio.
More
Azur is interested in late stage or marketed products for the US market
More
Displaying 1..3 of 3 -
per page
Order by